Entellus Medical (NASDAQ: ENTL) reported Q4 EPS of ($0.39), $0.06 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $21.7 million versus the consensus estimate of $21.44 million.

GUIDANCE:

Entellus Medical sees Q1 2017 revenue of $19-20 million, versus the consensus of $20.1 million.

Sees FY 2017 revenues of $86-90 million versus consensus of $90.5 million.

For earnings history and earnings-related data on Entellus Medical (ENTL) click here.